Invention Grant
- Patent Title: Reagent and method for fluorescence quantitative real-time PCR detection of RCL
-
Application No.: US16967659Application Date: 2019-01-21
-
Publication No.: US11697848B2Publication Date: 2023-07-11
- Inventor: Fang Liu , Liping Lan , Yutian Wei , Xun Ye , Li Zhang , Jiaqi Huang , Yihong Yao
- Applicant: CELLULAR BIOMEDICINE GROUP INC.
- Applicant Address: US MD Rockville
- Assignee: Cellular Biomedicine Group, Inc.
- Current Assignee: Cellular Biomedicine Group, Inc.
- Current Assignee Address: US MD Rockville
- Agency: Leason Ellis LLP
- Priority: CN 1810114113.2 2018.02.05
- International Application: PCT/CN2019/072576 2019.01.21
- International Announcement: WO2019/149107A 2019.08.08
- Date entered country: 2020-08-05
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C12Q1/6876 ; C12Q1/686 ; C12Q1/70

Abstract:
The present invention provides a reagent and method for detecting a replication-competent lentivirus (RCL) by fluorescence quantitative real-time polymerase chain reaction (PCR). In particular, the present invention provides a primer and probe combination for detecting RCL, and a method for performing detection using said primer and probe; the present invention also provides a reagent kit comprising said primer and probe. The primer and probe combination of the present invention detects RCL with high amplification efficiency and good specificity, and can be used for RCL detection and RCL monitoring of clinical patient peripheral blood samples which may occur during a production process.
Public/Granted literature
- US20210214789A1 REAGENT AND METHOD FOR FLUORESCENCE QUANTITATIVE REAL-TIME PCR DETECTION OF RCL Public/Granted day:2021-07-15
Information query